Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Kamada Ltd (KMDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
The Zacks Analyst Blog Highlights: American River, BG Staffing, Evolution Petroleum, Kamada and Farmers & Merchants

The Zacks Analyst Blog Highlights: American River, BG Staffing, Evolution Petroleum, Kamada and Farmers & Merchants

AMRB : 15.60 (unch)
EPM : 9.90 (-0.50%)
FMAO : 43.88 (-1.90%)
BGSF : 29.07 (+2.25%)
KMDA : 5.45 (+0.93%)
Dollar Strengthens on Turkey's Trouble: Top 5 Gainers

Lira loses more than 20% over the week as international markets react to the uncertainty over Turkey's capability to repay foreign-currency debts. Dollar hits a one-year high.

AMRB : 15.60 (unch)
EPM : 9.90 (-0.50%)
FMAO : 43.88 (-1.90%)
BGSF : 29.07 (+2.25%)
KMDA : 5.45 (+0.93%)
Kamada (KMDA) Surpasses Q2 Earnings and Revenue Estimates

Kamada (KMDA) delivered earnings and revenue surprises of 55.56% and 14.20%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

KMDA : 5.45 (+0.93%)
Kamada Reports Financial Results for Second Quarter and First Six Months of 2018

-- Total Revenues for First Half of 2018 were $51.3 Million, a 16% Increase Over First Half of 2017

KMDA : 5.45 (+0.93%)
Kamada to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on August 7

Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the quarter and six months ended June 30, 2018, prior to the...

KMDA : 5.45 (+0.93%)
Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT

Kamada Ltd. (the "Company") (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that it has received positive scientific advice from the Committee for Medicinal Products...

KMDA : 5.45 (+0.93%)
Is Kamada (KMDA) Outperforming Other Medical Stocks This Year?

Is (KMDA) Outperforming Other Medical Stocks This Year?

KMDA : 5.45 (+0.93%)
4 Undervalued MedTech Stocks to Consider Amid Volatility

Amid turbulences of the U.S. market, some value stocks of MedTech industry appear to be lucrative investment options.

ANIP : 56.41 (+1.06%)
CRHM : 3.95 (+4.64%)
CPSI : 27.10 (-0.73%)
KMDA : 5.45 (+0.93%)
5 Biotech Stocks Under $10 Worthy of Investors' Attention

Small biotech stocks are good bets with lower market cap as well as share price.

MNLO : 7.71 (-2.53%)
SHPG : 170.42 (-0.63%)
CYTR : 1.10 (+2.80%)
KMDA : 5.45 (+0.93%)
BLPH : 0.79 (+21.54%)
SNSS : 1.95 (-5.34%)
SNY : 42.04 (+1.92%)
Results of Kamada's Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients to be Presented at the Upcoming American Diabetes Association's 78th Scientific Sessions

Kamada Ltd. (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that the results from the Company's Phase 2 trial of Alpha-1 Antitrypsin (AAT) in newly diagnosed type-1...

KMDA : 5.45 (+0.93%)
Kamada Ltd to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 15, 2018 / Kamada Ltd (NASDAQ: ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 15, 2018 at 8:30 AM Eastern Time.

KMDA : 5.45 (+0.93%)
Kamada Reports Financial Results for First Quarter of 2018

-- U.S. Launch of KEDRAB(R) [Human Rabies Immune Globulin (HRIG)] Represents Significant Company Milestone

KMDA : 5.45 (+0.93%)
Kamada to Announce First Quarter 2018 Financial Results and Host Conference Call on May 15

Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the quarter ended March 31, 2018, prior to the open of the...

KMDA : 5.45 (+0.93%)
Kedrion Biopharma and Kamada Announce KEDRAB(R) (Rabies Immune Globulin [Human]) Now Shipping; Distribution Timed to Meet Spring/Summer Demand for Product

Kedrion Biopharma and Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), two leading human-derived protein therapeutics companies, announced today that KEDRAB(R) [Rabies Immune Globulin (Human)]...

KMDA : 5.45 (+0.93%)
Israel-based Medical Cannabis Solutions Provider, Kanabo Research, has Signed an Agreement With Constance Therapeutics From the US

Israeli startup Kanabo Research, which develops clinical solutions for extraction and vaporization of medical cannabis, announces it is entering an agreement with Constance Therapeutics, a US-based medical...

KMDA : 5.45 (+0.93%)
Israel-based Medical Cannabis Solutions Provider, Kanabo Research, has Signed an Agreement With Constance Therapeutics From the US

TEL AVIV, Israel , April 25, 2018 /PRNewswire/ -- Israeli startup Kanabo Research , which develops clinical solutions for extraction and vaporization of medical cannabis, announces it is entering...

KMDA : 5.45 (+0.93%)
Kamada Received Feedback from FDA on Proposed Phase 3 Protocol for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

Kamada Ltd. (the "Company") (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that the Company recently received feedback from the U.S. Food and Drug Administration...

KMDA : 5.45 (+0.93%)
Kamada Announces Nomination of Three New Members to its Board of Directors

Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that the Company Board of Directors has nominated three new directors...

KMDA : 5.45 (+0.93%)
Kamada to Announce Third Quarter 2017 Financial Results and Host Conference Call on November 13

Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that it will release financial results for the third quarter ended September...

KMDA : 5.45 (+0.93%)
Kamada Announces Top-line Results of Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients

Efficacy trend was demonstrated in the pre-determined sub group of patients between the ages of 12 to 18, treated with the higher dose of 120mg/kg

KMDA : 5.45 (+0.93%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC +1.23 , FTNT -0.09 , CAKE +0.97 , PLT +0.52 , AEO +0.88
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed the day with fractional to 1 cent losses in most nearby contracts, as September was up 1.82% on the week. CFTC data on Friday showed spec traders trimming their net short position in corn futures and options by 4,743 contracts dur...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar